It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening.
Editorial Article
Overview
abstract
The benefit-harm ratio of PSA screening can be dramatically improved by avoiding screening, biopsy and treatment in men who are unlikely to benefit, and by referring men that do need treatment to high volume centers.
